These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9806213)

  • 1. In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonists.
    Han HK; Stewart BH; Doherty AM; Cody WL; Amidon GL
    Life Sci; 1998; 63(18):1599-609. PubMed ID: 9806213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.
    Doherty AM; Cody WL; He JX; DePue PL; Cheng XM; Welch KM; Flynn MA; Reynolds EE; LaDouceur DM; Davis LS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S98-102. PubMed ID: 7510009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL; He JX; Reily MD; Haleen SJ; Walker DM; Reyner EL; Stewart BH; Doherty AM
    J Med Chem; 1997 Jul; 40(14):2228-40. PubMed ID: 9216842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of oral delivery for hexapeptide endothelin antagonists.
    Stewart BH; Reyner EL; Tse E; Hayes RN; Werness S; He JX; Cody WL; Doherty AM
    Life Sci; 1996; 58(12):971-82. PubMed ID: 8786709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
    J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of renal and systemic responses to endothelin-1 infusion with PD 145065.
    Wellings RP; Corder R; Doherty AM; Vane JR
    Eur J Pharmacol; 1994 Apr; 256(2):201-4. PubMed ID: 8050471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.
    Yamamoto A; Taniguchi T; Rikyuu K; Tsuji T; Fujita T; Murakami M; Muranishi S
    Pharm Res; 1994 Oct; 11(10):1496-500. PubMed ID: 7855059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocapnic constriction in rabbit basilar artery in vitro: triggering by N(G)-monomethyl-L-arginine monoacetate and dependence on endothelin-1 and alkalosis.
    Zuccarello M; Lee BH; Rapoport RM
    Eur J Pharmacol; 2000 Aug; 401(2):213-9. PubMed ID: 10924929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
    Gardner A; Westfall TC; Macarthur H
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
    Semler DE; Ohlstein EH; Nambi P; Slater C; Stern PH
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1052-8. PubMed ID: 7891315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
    Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration.
    Kiriyama A; Fujita K; Takemura S; Kuramoto H; Kiso Y; Takada K
    Biopharm Drug Dispos; 1994 Oct; 15(7):617-26. PubMed ID: 7849237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
    Uchiyama T; Kotani A; Kishida T; Tatsumi H; Okamoto A; Fujita T; Murakami M; Muranishi S; Yamamoto A
    J Pharm Sci; 1998 Apr; 87(4):448-52. PubMed ID: 9548897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
    Lanese DM; Conger JD
    J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
    Lee HJ; Amidon GL
    Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.
    Bai JP
    Pharm Res; 1995 Jul; 12(7):1101-4. PubMed ID: 7494810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contractile effects of endothelins on the smooth muscle of the rat prostate gland.
    Salamoussa A; Lau WA; Pennefather JN; Ventura S
    Eur J Pharmacol; 2000 Sep; 403(1-2):139-45. PubMed ID: 10969155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
    Potts W; van Horn R; Anderson K; Blake T; Garver E; Joseph G; Dreyer G; Shu A; Heys R; Fong KL
    Drug Metab Dispos; 1995 Aug; 23(8):799-805. PubMed ID: 7493545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.